Key facts
- It has raised $1.7M; the latest was Seed Round ($1.2M) in Mar 2025.
- Notable investors include Y Combinator, Soma Capital, Global Founders Capital, Slow Ventures, Attack Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for HealOS
- ·The full record, as it builds
Funding rounds
No funding rounds for HealOS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HealOS
Developer of an artificial intelligence-powered healthcare workflow platform designed to automate clinical documentation and operational tasks for medical practices. The company's platform uses multiple task-specific automation agents to generate structured clinical notes with coding outputs, handle inbound patient calls for scheduling and intake, verify insurance eligibility details, submit and track prior authorization requests, extract and route information from faxes and referrals, and support claims and denial-management workflows, enabling clinics, hospitals, and specialty practices to reduce manual operations work and improve process turnaround.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 4
- Website
- healos.ai/
- Ownership
- Privately Held (backing)
HealOS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HealOS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HealOS in its N-PORT filings yet. We sweep new filings monthly.